Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment header formatting; replaced the old Intervention / Treatment header and added a page revision note of Revision: v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedA new deployment revision label 'Revision: v3.5.5' was added and the previous label 'Revision: v3.5.4' removed, indicating a backend update that does not affect study content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's Revision label was updated from v3.5.3 to v3.5.4, signaling a new maintained version of the page for internal tracking and QA.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page footer was updated to reflect a newer system revision (from v3.5.2 to v3.5.3), without changing the displayed study information.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision metadata updated to show v3.5.0, replacing the older v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.